1. www.q1productions.com
CUSTOMER CENTRIC MEDICAL
INFORMATION
3RD ANNUAL
JULY 25-26, 2016 | BOSTON, MA
DISTINGUISHED PRESENTERS INCLUDE:
PHYSICIAN AND PATIENT PERSPECTIVES:
CONFERENCE SPONSORS:
BRONZE: EXHIBITING: TABLE TOP:
Transforming Medical Information through the Globalization of Processes & the Implementation of
Innovative Communication Channels while Leveraging Metrics & Physician Feedback to Ensure the
Dissemination of Compliant, Accurate & Valuable Medical Information Content
Anjali Shah
Director, Global Medical Information
CELGENE
Donna Booth
Director, Medical Information
GLAXOSMITHKLINE
Thomas Malieckal
Director, Global Medical Information
CELGENE
Philip Fuller
Director, Medical Information
& Promotional Medical Review
MALLINCKRODT
Michael Rocco
Director, Business Planning &
Communication – Americas, Global
Medical Information
PFIZER
Steven Hays
Director, Digital Channels
PFIZER
Angela Guerra Alvarez
Associate Director, Global Medical
Communications
BIOGEN
Rania Gaspo
Director, Regional Therapy Area Lead
North America Medical Information
PFIZER
Dr. Elizabeth Lathers
Director, Medical Information
EMD SERONO
Christopher Keenan
Worldwide Medical Contact & Insights
BRISTOL-MYERS SQUIBB
Jimmie Overton
Sr. Dir. Medical Scientific Information &
Medical Education
ALLERGAN
Torrey Cope
Partner
SIDLEY AUSTIN LLP
Ann Daniele
Executive Director, Medical, Technical &
Customer Information
BOEHRINGER-INGELHEIM
Salvatore Barone
Associate Director, Medical Information
BOEHRINGER-INGELHEIM
Stacey Fung
Associate Director, Medical
Communications
GENENTECH
Jay Kissel
Director, Medical Information, Oncology
ELI LILLY
Dr. Sarika Sood
Director, North America Lead, Global
Medical Information
BAXALTA
Scott McConnell
Senior Director, Medical Affairs
CHIASMA
Janet Gottlieb, Ph.D.
Director, Health Science Associates
ALLERGAN
Iris Tam
Vice President, Patient Access & Quality,
Medical Affairs
OTONOMY
Gigi Shafai
Associate Director, Medical Information
Management
IRONWOOD PHARMACEUTICALS
Kevin J. Fowler
Kidney Advocacy Committee
NATIONAL KIDNEY FOUNDATION
Patient Family Partnership Council
KIDNEY HEALTH INITIATIVE
Robert A. Gabbay, MD, Ph.D.
Chief Medical Officer
JOSLIN DIABETES CENTER
Rebecca Grochow Mishuris, MD, MS,
MPH
Assistant Chief Medical Information
Officer
BOSTON MEDICAL CENTER

2. 7:30 REGISTRATION & MORNING COFFEE
8:20 OPENING REMARKS
8:30 CHAIRPERSON’S CONFERENCE WELCOME & KEYNOTE ADDRESS
As the continuum of healthcare continues to evolve, integrating new priorities and concerns from HCPs, payers and consumers, medical information executives
play a crucial role in ensuring accurate, compelling and accessible information is provided. The function and importance of medical information as a strategic
business partner continues to increase, as departments across the organization including marketing and safety increasingly look to medical information teams for
data, analysis and first-hand feedback from partners in healthcare. While forecasting the future of healthcare delivery is not possible, medical information teams
will continue to play a vital role in the dissemination of product data, ensuring the safe and effective use of new and existing products.
8:45 PHYSICIAN PERSPECTIVES PANEL: FOSTERING AN OPEN DIALOGUE TO ADVANCE MEDICAL INFORMATION
As a vast majority of medical information content is developed, it is vital to incorporate the physician perspective throughout all aspects of the creation and dissem-
ination of production information. Communication preferences, physician workflow, patient profiles and healthcare delivery practices are a few of the factors that
medical information teams must consider when developing relevant and accurate MI content for HCPs. This panel will provide attendees with a unique opportunity
to enter an open dialogue with a variety of physicians regarding the dissemination of medical information to ensure patient safety and treatment effectiveness.
• Physician workflow: implementing optimal communication channels
• Reviewing HCP communication preferences for medical information
• Understanding how and when physicians access information
MODERATOR:
Christopher Keenan, BRISTOL-MYERS SQUIBB
PANELISTS:
Rebecca Grochow Mishuris, MD, MS, MPH, BOSTON MEDICAL CENTER
Robert A. Gabbay, MD, Ph.D., JOSLIN DIABETES CENTER
9:30 COLLECTING VALUABLE FEEDBACK FROM HCP SURVEYS TO STEER MEDICAL INFORMATION STRATEGIES
Customer feedback surveys provide insightful perspectives and information through measuring how medical information content is adequately addressing HCP
needs in terms of content delivery and communication preferences for medical information. The execution of surveys vary from organization to organization, and
ensuring HCP buy-in along with an adequate number of responses can be attributed to the construction of a survey, including survey length, questions asked and
delivery methods. With the goal of obtaining valuable feedback to influence medical information strategies, this session will provide a discussion on various survey
options, as well as reviewing customer feedback to fuel impactful changes with acquired insights.
• Effective delivery methods for feedback surveys
• Applying information gathered to drive change in MI
• Considerations when creating a medical information survey
Stacey Fung, Associate Director, Medical Communications, GENENTECH
10:15 COFFEE & NETWORKING BREAK
10:45 WORKSHOP: TRANSFORMING MEDICAL INFORMATION CONTENT TO MEET EVOLVING CUSTOMER NEEDS
In recent years, various communication channels have become available to disseminate medical information to healthcare professionals; while these new com-
munication methods can be impressive, content should remain the foundation for engaging physicians. The medical information letter has traditionally been the
primary content asset developed and utilized to communicate with key stakeholders. With a rapidly evolving healthcare landscape, it is vital that leaders in medical
information collectively drive a paradigm shift in content development to deliver innovative, value-add content through multiple channels. Through this interactive
75-minute workshop, the facilitator will guide attendees through a thought provoking exercise to define the future of MI content. Discussion will include:
• Optimal redesign of standard response letters
• Identification of additional content types
Anjali Shah, Director, Global Medical Information, CELGENE
12:00 LUNCHEON FOR ALL ATTENDEES, SPEAKERS & SPONSORS
CUSTOMER CENTRIC MEDICAL INFORMATION
TRACK ONE TRACK TWO
1:00 BENCHMARKING WEBSITES: UNCOVERING OPPORTUNITIES FOR
ENHANCING THE DISSEMINATION OF MEDICAL INFORMATION
As physicians increasingly utilize online sources of medical information to rap-
idly gather information regarding products, medical information teams must
ensure that material presented online provides a high level of usability, balanc-
ing the level and quantity of data provided to optimize use. Corporations are
often unsure how to meet this delicate equilibrium, and as a result, leading cor-
poration Pfizer undertook a study of pharmaceutical websites in order to under-
stand how information is presented and viewed in order to enhance the func-
tionality of medical information websites. Results from the study will provide
session participants with high level insight into the fundamental characteristics
of successful medical information portals with valuable take away lessons.
• Ensuring a user-friendly, easily searchable website
• Analyzing MI websites based on company size & capabilities
• Review of anonymous rankings based on website analysis
• Sharing insights to update medical information websites
Rania Gaspo, Dir., Regional Therapy Area Lead, North America Medical
Information, PFIZER
1:45 ANALYZING THE BENEFITS AND RESTRICTIONS IN
COMMUNICATING CLINICAL TRIAL DATA
For medical information teams rapidly responding to product inquiries, com-
plexities can arise surrounding the disclosure of clinical trial data, specifically
regarding adverse events. Although companies have standard operating proce-
dures outlining releasable information, challenges occur with newly marketed
drugs and the question of whether the adverse event is in direct correlation
with product use. Due to the highly regulated landscape, certain companies
look at clinical trial data as proprietary and therefore do not allow the relay of
any information that is not currently published. A legal perspective will give MI
teams insight into the challenges surrounding the usage of clinical trial data
and the value of incorporating studies into Medical Information SOP’s.
•Regulatory and legal concerns in sharing clinical trial data
• Keeping patient safety first in HCP communications
• Scenarios where use of clinical information is valuable
Torrey Cope, Partner, SIDLEY AUSTIN LLP
1:00 CREATING AN AUTHENTIC PARTNERSHIP WITH PATIENT
ADVOCACY GROUPS TO ADVANCE MEDICAL INFORMATION
Although the majority of medical information content is developed for HCPs,
patients are also key stakeholders in the healthcare industry and the move
towards a patient-centric healthcare environment illustrates the need for orga-
nizations to partner with advocacy groups to remain at the forefront of change.
Patient advocacy and pharmacist groups become crucial partners for life sci-
ence organizations when determining what patients want in terms of content
and communication channels for medical information. The utilization of advo-
cacy and pharmacist group insights gives medical information teams the ability
to foster improvement of the patient experience by using direct feedback to
facilitate change within organizations and ultimately improve patient care.
• Gathering patient insights from patient advocacy and pharmacy groups
• Collecting information to identify the patient perspective
• Utilizing patient feedback to drive transformation in medical information
Kevin J. Fowler, Kidney Advocacy Committee, NATIONAL KIDNEY FOUNDATION
Patient Family Partnership Council, KIDNEY HEALTH INITIATIVE
1:45 BENEFITS & OPPORTUNITIES IN COMMERCIAL PARTNERSHIPS &
IMPACT ON MEDICAL INFORMATION
For many pharmaceutical and biotechnology corporations, commercial partner-
ships provide an opportunity to leverage resources and experience in specific
industry segments, increasing the awareness of new and existing therapies.
However, these partnerships can also cause challenges in the effective deliv-
ery of medical information as groups on either side of the partnership look to
determine a unified path for medical information delivery. A recent partnership
between industry leaders EMD Serono and Pfizer resulted in a number of posi-
tive outcomes for both organizations, providing valuable learning opportunities
for medical information dissemination as a result of the integrated partnership.
Dr. Elizabeth Lathers, Director, Medical Information
EMD SERONO
• Considerations for operationalizing a ‘multi-content’ capability, globally
• Considerations for multi-channel communications
DAY ONE CONTINUED...
DAY ONE | MONDAY, JULY 25

3. 2:30 COFFEE & NETWORKING BREAK
3:00 COMPONENT AUTHORING: GAINING EFFICIENCY IN UPDATING CONTENT
As groups’ responsibilities and geography expand there is value expected in the ability to leverage global resources and the re-use of content whether created by
yourself or other colleagues. In Medical Information, the response document is one area of high potential for re-use of content. What if technology enabled us to
update the same content that existed in multiple documents by revising it in only one place? What if you created content once and were able to use it automatically
via multiple formats (e.g., printed documents, websites, mobile devices, e-mail). In this session, we will present the journey to date of one company from research
through proof-of-concept to pilot. Additionally, a vendor in this space will provide insights into how this technology has been used in other areas.
• Evaluate content and the potential benefit of the change
• Considerations when identifying a partner and defining a plan
• Initial findings and discussion
Michael Rocco, Director, Business Planning & Communication – Americas, Global Medical Information, PFIZER
3:45 IMPLEMENTING INNOVATIVE COMMUNICATION CHANNELS FOR MEDICAL INFORMATION
As technology advances, medical information executives find that implementing new mediums of communication can meet the varying needs and communica-
tion preferences of customers. Social media, click-to-chat, video calling and other multimedia channels provide customers with the opportunity to solicit medical
information in a convenient manner; however, deciding to spend time and resources to implement these novel communication channels requires an analysis of
capabilities, communication preferences, and HCP workflow. The following presentations will be 20 minute case studies illustrating how organizations have imple-
mented new and innovative communication channels.
CLICK-TO-CHAT - Ann Daniele, BOEHRINGER- INGELHEIM
VIDEO CONFERENCE - Steven Hays, PFIZER
4:45 UTILIZATION OF MEDICAL INFORMATION INSIGHTS TO DRIVE VALUE & RETURN ON INVESTMENT
While metrics can substantially improve the delivery of medical information to physicians, payers and patients, data is often of tremendous value to additional teams
within the corporation, most notably marketing and medical affairs teams. Providing trend analysis on common queries, or ar­eas where data gaps exist or new indica-
tions can be identified is of great strategic value to pharma corporations, underscoring the critical importance of the MI function. Of further value are insights that can
be provided to marketing and customer facing teams, who are always eager for direct feedback on promotional and commercial efforts. Additionally, insights obtained
through external customer feedback can also provide tremendous value in informing content types, format, and channels utilized in responding to HCP inquiries.
Thomas Malieckal, Director, Global Medical Information, CELGENE
5:30 CLOSING REMARKS & END OF DAY ONE CONFERENCE
DAY ONE | MONDAY, JULY 25 (CONTINUED)
7:30 REGISTRATION & MORNING COFFEE
7:50 CHAIRPERSON’S MORNING REMARKS
8:00 AMCP DOSSIER UPDATE: NEW GUIDELINES FOR MEDICAL INFORMATION
The AMCP Formulary Dossier has undergone a change in structure and new guidelines have been released for medical information teams developing these
reports. Modifications to the AMCP Formulary Dossier are in response to an evolving environment requiring robust evidence to support the value of innova-
tive treatments in healthcare and in response to feedback from payers desiring additional medical information than previously offered. The 4.0 version of
AMCP’s Formulary Dossier guidelines will address new topics that have not been included before including handling information requests for companion di-
agnostic tests and biosimilars along with clarification of existing topics to improve communication between pharma manufacturers and payer organizations.
• Overview of new components in AMCP Formulary Dossier
- Companion diagnostic tests
- Biosimilars and handling requests
• Determining relevant clinical & economic data for Formulary Dossier
• Methods for accurate product positioning by medical information teams
Iris Tam, VP, Patient Access & Quality, Medical Affairs
OTONOMY
8:45 RESPONDING TO PAYER REQUESTS FOR MEDICAL INFORMATION
In recent years, medical information departments have seen an increase in requests from healthcare plans and managed care organizations, prompting phar-
maceutical companies to review current practices for positioning products accurately within medical information content. Organizations like AMCP have outlined
industry guidelines for responding to payer inquiries, which has provided medical information teams with a foundation for compliant response letters. Additionally,
medical information executives can also work alongside HEOR and MSL counterparts to generate outcomes-based standard response documents that will offer
payers robust data on an innovative therapy.
• Positioning products accurately within managed care responses
• Recognizing the payer perspective when developing MI content
• Leveraging internal expertise on health economics & outcomes research
Donna Booth, Director, Medical Information
GLAXOSMITHKLINE
9:30 COFFEE & NETWORKING BREAK
10:00 CASE STUDY: LEVERAGING A PATIENT-CENTRIC APPROACH IN MEDICAL INFORMATION
As the life science industry continues to evolve towards a more patient-centered landscape, MI executives must consistently connect with customers, as well as
provide desired medical information in an engaging and accessible way. With the goal of improving patient outcomes in mind, manufacturers must evaluate patient
needs and communication preferences when outlining a medical information strategy. This case study example will offer attendees an inside look at how one
company has taken effective measures to create a patient-centric design for medical information practices.
• Instilling patient-centricity into a company culture
• Surveying to uncover patient needs and preferences
• Assessment of MI channels in patient communication
• Adapting medical information writing in a patient-centric model
Gigi Shafai, Associate Director, Medical Information Management
IRONWOOD PHARMACEUTICALS
CUSTOMER CENTRIC MEDICAL INFORMATION
DAY TWO | TUESDAY, JULY 26
DAY TWO CONTINUED...

4. 10:45 PANEL DISCUSSION: ENHANCING PROMOTIONAL MATERIAL REVIEW PROCESSES THROUGH MEDICAL INFORMATION OVERSIGHT
For many medical information executives, an additional responsibility of reviewing promotional materials is shouldered, as medical information teams join medical
affairs, legal and regulatory groups in ensuring promotional materials are medically and scientifically accurate and meet regulatory guidelines. As the many po-
tential channels of communication and information distribution have increased to include television advertising, online and digital promotion as well as traditional
print based advertising, medical information teams must have the ability to quickly and effectively review promotional materials. Balancing the need to promote
new and existing products alongside maintaining compliance with regulatory frameworks for promotion is challenging, but a set format for analysis will guide
executives towards a positive conclusion.
• Core areas to analyze for compliant promotion
• Strategies for cross-checking scientific data
• Citation methods and best practices in promotion
• Establishing a consensus across varied groups
CASE STUDY:
Janet Gottlieb, Ph.D., Director, Health Science Associates, ALLERGAN
PANEL:
Salvatore Barone, Associate Director, Medical Information, BOEHRINGER-INGELHEIM
Mabel Lam Tse, Director, Medical Information, RETROPHIN
Jimmie Overton, Sr. Dir. Medical Scientific Information & Medical Education, ALLERGAN
11:45 PANEL DISCUSSION: CENTRALIZED V. DECENTRALIZED FOR GLOBAL MEDICAL INFORMATION
For medical information teams distributing content globally, creating a global strategy unique to a company’s products, regional markets and customers plays
an integral part in ensuring HCP’s have access to the appropriate resources. A centralized strategy utilizes a single US-based hub to perform the initial medical
information content creation, which is then distributed by local offices worldwide. For decentralized models, regional medical information teams have complete
control of content development, due to a stronger familiarity with local languages, communication preferences and an understanding of the regional healthcare
landscape. During an interactive panel discussion, industry leaders will discuss the concept and execution of globalization unique to each organization to dig
deeper into the opportunities and challenges posed by each global model.
• Decision making criteria in global content development
• Enhancing the reach of medical information worldwide
• Debating the opportunities of a centralized vs decentralized model
Rania Gaspo, PFIZER
Scott McConnell, CHIASMA
Jimmie Overton, ALLERGAN
Salvatore Barone, BOEHRINGER-INGELHEIM
12:30 LUNCHEON FOR ALL ATTENDEES, SPEAKERS & SPONSORS
1:30 SMALL GROUP DISCUSSIONS: KEY CHALLENGES WITHIN MEDICAL INFORMATION
Medical information executives within pharmaceutical companies encounter different challenges and obstacles on a sometimes daily basis, with little or no pre-
dictability related to what might come next. These discussions will provide a forum for the sharing of ideas and networking, which are of high value to MI teams.
The topics for discussion have been previously selected based on feedback received by conference registrants. Attendees, speakers and sponsors are encouraged
to be active participants allowing for better exchange of ideas, peer-to-peer learning and open discussion.
• Integration of Data Analytics to Improve Delivery & Impact of Medical Information
• Customizing Medical Information Content for Physicians Worldwide
• Effective Methods for the Harmonization of Medical Information Processes
Christopher Keenan, Worldwide Medical Contacts & Insights, BRISTOL-MYERS SQUIBB
2:15 CUSTOMIZING SCIENTIFIC INFORMATION CONTENT FOR MEDICAL FIELD TEAMS WORLDWIDE
Medical field teams worldwide need to provide clear and accurate scientific information to healthcare professionals as part of their medical support activities. Pro-
viding useful resources at global level facilitates the daily tasks of field medical teams and ensure consistent medical communication across regions. Empowering
the medical field teams as a communication channel for delivering medical information enables a more personalized approach to address the physician’s requests
and overcomes some of the barriers in disseminating medical information. Through the customization of medical information at global level, content delivery can
be executed swiftly and accurately to physicians requesting product information.
• Development of medical scientific content on a global scale
• Barriers in disseminating medical information
• Communication channels to enable readily accessible information worldwide
Angela Guerra Alvarez, Associate Director, Global Medical Communications, BIOGEN
3:00 COFFEE & NETWORKING BREAK
3:30 PANEL: BENEFITS & CHALLENGES OF MEDICAL INFORMATION CALL CENTER INSOURCING V. OUTSOURCING
As medical information teams respond to HCP inquiries, employing the use of a call center is oftentimes the most effective option for providing direct contact.
Benefits of operating an internal call center include increased oversight and reduced employee turnover; however, it also oftentimes requires significant financial
and staff investment, as well as constant technological updates and training requirements which consume valuable resources. An assessment of hosting the call
center in-house, outsourcing the call center, or utilizing a combination of the two business models, will allow medical information executives to determine the ideal
operational set-up for an organization.
• Determining the ideal call center model & gauging effectiveness
• Identifying key metrics utilized in the decision-making process
• Call center operations for organizations of differing sizes
• Assessing difficulty of content being presented in the outsourced model
Scott McConnell, CHIASMA
Philip Fuller, MALLINCKRODT
Ann Daniele, BOEHRINGER-INGELHEIM
Mabel Lam Tse, RETROPHIN
Dr. Sarika Sood, BAXALTA
4:15 CASE STUDY: STRATEGIES FOR SELECTING THE IDEAL VENDOR FOR MEDICAL INFORMATION CALL CENTER
As pharmaceutical and medical device companies streamline customer service requests and on-demand access to production information, MI teams oftentimes
partner with an outside vendor for cost-effectiveness and maximization of internal resources for content development and strategic projects. When selecting the
ideal vendor, it is important to evaluate the vendor’s overall services, skills, and knowledge as call centers are an extension of the organization’s brand and should
provide adequate support to HCP’s. A case study example of the vendor selection process including common pitfalls to avoid and key factors to consider, will assist
MI teams in choosing the best call center provider.
• Factors to consider in determining a first class partnership
• Ensuring vendor capabilities align with manufacturer expectations
• Methods for improving the vendor/client partnership in medical information
Philip Fuller, Director, Medical Information & Promotional Medical Review, MALLINCKRODT
5:00 CLOSING REMARKS & CONFERENCE CONCLUSION
DAY TWO CONTINUED...
CUSTOMER CENTRIC MEDICAL INFORMATION

5. RELATED EVENT
Senior Medical Information Specialist, ABBOTT
Medical Director, ABBOTT
Senior Manager, Global Medical Affairs R&D IT, ABBVIE
Regional Manager, MSLs, ABBVIE
Director, Global Training, ABBVIE
Medical Information Manager, ACELITY
Senior Medical Info. Specialist, ACORDA THERAPEUTICS
Assoc. Dir., Medical Information, ACORDA THERAPEUTICS
Dir., Scientific Services & Content Compliance, ACTELLION
Head, U.S. Medical Product Info Contact Center, ALCON
Global Head Field Clinical & Scientific Affairs, ALCON
Senior Director, Global Medical Information, ALEXION
Assoc. Dir. Scientific Comm., Medical Affairs, ALEXION
Dir. of Global Medical Communications, Urology, ASTELLAS
Exec Director, Medical Communications Global, ASTELLAS
Senior Director, Medical Communications, ASTELLAS
Assoc. Dir., Medical Info, Global Medical Affairs, BAXTER
Senior Manager, Global Medical Information, BAXTER
Medical Information Specialist, BAXTER
ED, Medical & Technical Info, BOEHRINGER INGELHEIM
Senior Manager, Medical Information & Congress, BIOGEN
Head, Specialty Medical Information, BMS
Dir., Global Medical Contact Centers - CRM Americas, BMS
Executive Director, WW Medical Scientific Content, BMS
Exec. Dir., US Medical Information & Field Operations, BMS
Lead, Medical Information, Oncology, BMS
Director, Worldwide Medical Contact, BMS
Executive Director, Global Medical Information, CELGENE
Sen. Dir., Strategic Medical Comm. & Innovation, CELGENE
Advisor Global Customer Analytics & Insights, ELI LILLY
Dir., Medical Information Strategy & Operations, ELI LILLY
Global Medical Information Consultant, ELI LILLY
Director, Medical Information, EMD SERONO
Director, Medical Information, US Pharma, GSK
Director of Medical Information, Vaccines, GSK
Manager, Medical Information, JANSSEN
Associate Director, Medical Information, JANSSEN
Director, Medical Information, JANSSEN
Sen. Mgr., Med. Info & Affairs, JAZZ PHARMACEUTICALS
Dir., Glo. Med. Info. & Promotional Review, MALLINCKRODT
Exec Dir. & US Oncology Medical Information, NOVARTIS
Associate Director of Global Medical Information, NOVARTIS
Manager, Medical Information, NOVARTIS
Medical Information Director, NOVARTIS
Associate Director, Medical Information, OTSUKA
Senior Compliance Counsel, OTSUKA
Regional Senior Director, Medical Information, PFIZER
Associate Director, Medical Information, PFIZER
Director, Innovation, SANOFI
Dir., Medical Comm & Info., Medical Affairs, SEQIRUS
Mgr. of Medical Communications, Neurosciences, SHIRE
Head, Global Medical Communications, SHIRE
Director, Medical Communications, TAKEDA
Senior Manager Medical Communications, TAKEDA
US Medical Information, TEVA PHARMACEUTICALS
Senior Dir., Medical Information, TEVA PHARMACEUTICALS
Director, Global Medical Information, VERTEX
Associate Director, Global Medical Information, VERTEX
Asst. Dir. Global Medical Information, VERTEX
Sen., Dir., Global Patient Safety/Medical Info, VERTEX
…AND MANY MORE
PREVIOUS ATTENDEES INCLUDE:
Development of a Strategic Timeline for Medical
Affairs Activities to Support Pre-Commercial Launch
Activities, Gain Support of Key Opinion Leaders,
Create Disease Awareness and Payer Support, to
Ultimately Ensure Product Launch Success
• Unrivaled opportunity to learn how effective pre-launch
medical affairs activities are securing product success
• Case studies highlighting the impact of pre-launch
medical affairs activities and strategies for measuring
effectiveness
• Varied perspectives from corporations large and small
will demonstrate success at all levels & budgets
• Leading industry experts represent executives from
corporations including Pfizer, AstraZeneca, Sanofi,
AbbVie, UCB Pharmaceuticals
• Attendance is restricted, encouraging active
participation & improved networking through a smaller
group setting
• Limited vendor participation ensures that content shared
is high-level and immediately applicable to industry
leaders
MEDICAL AFFAIRS PRE-LAUNCH
COMMERCIAL STRATEGIES
JUNE 23-24, 2016 | BOSTON, MASSACHUSETTS
CUSTOMER CENTRIC MEDICAL INFORMATION
JULY 25-26, 2016 | BOSTON, MA
Executives that will find this program of greatest relevance
are those currently developing medical information con-
tent for pharmaceutical and medical device companies. Job titles
of those executives that will find this program to be most applica-
ble to their job functions include:
• Medical Information
• Medical Information Specialists
• Medical Affairs
• Medical Communications
At this time, there are a variety of sponsorship and exhi-
bition opportunities available for companies wishing to
increase their visibility and participation in the program, ranging
from keynote speaking opportunities through to exhibitor and
documentation sponsors. Organizations most suitable for this
type of exposure provide services and solutions including:
WHO SHOULD ATTEND: SPONSORSHIP OPPORTUNITIES:
• Contact Center Service Providers
• Mobile Application Developers
• Medical Information Consultants
• Medical Information Databases
• Dossier Development Experts
• Medical Writing Consultancies
• Cloud-Based Medical Information
• Component Authoring Solutions
• Patient Support Platforms